Protecting product pipeline and rising above competition through optimisation of operationally efficient, specifically targeted oncology clinical trials
We are pleased to announce the Clinical Operations in Oncology conference will be returning for its 3rd Annual edition in the friendly city of Amsterdam.
Our 2016 event will look to explore new ways to improve operational efficiencies within oncology trials and cover a series of interesting topics such as patient centricity, monitoring, patient recruitment & retention and global oncology trials.
Do not miss out on the unique opportunity to hear from pharma and biotech companies such as Eli Lilly, Merck Serono and Karus Therapeutics, at the only event specifically focused on the operational issues within oncology trials.
Risk based monitoring (RBM) involves the identifying, assessing, monitoring and mitigating of the risks that may impinge on the quality or safety of a study. These risks are continually reviewed throughout the study.
Clinical Operations in Oncology Trials attracts an audience from pharmaceutical companies across Europe involved in oncology trials. With the myriad of challenges specific to oncology trials we seek to create a specialised event to help guests deliver timely and cost effective clinical trials.
With regulatory bodies requesting more and more for pharma and biotech companies to incorporate patient centricity, there is a growing need for the oncology community to come together and share new tools and approaches , which can help make oncology clinical trials more patient centric.
The field of oncology is continuously evolving, and due to the elevated level of complexity of oncology trials compared to other therapeutic areas, there will always be new and interesting topics to discuss. New solutions arise, aiding companies to develop to fit the times and keep moving the sector forward.
Our 2015 event was hugely successful but don’t take it our word for it. Hear what our 2015 attendees said about the event:
The 2016 CTO Europe event will be providing informative and current content all driven to help improve your oncology clinical trials.